The Air Force Doesn't Want Lockheed Martin's New Stealth Drone -- but Lockheed Is Building 5 of Them Anyway

Lockheed Martin was excluded from the U.S. Air Force's initial Collaborative Combat Aircraft production awards, which went to private companies Anduril and General Atomics, but remains eligible for future drone-software contracts. Lockheed is self-funding five Vectis stealth drones, with the first flight targeted for late 2027, in hopes that the Air Force expands future CCA procurement. The strategy carries execution and customer-adoption risk, though Lockheed generated $8.7B of free cash flow and $6.3B of net income over the past 12 months; analysts project more than 19% annual earnings growth over five years.

Analysis

CCA procurement is shifting value away from a single prime-platform award toward autonomy, mission systems, integration, and recurring upgrade work. RTX is the clearest listed beneficiary because it has exposure to the software layer without bearing air-vehicle development risk; NOC and LMT retain optionality through the open-vendor architecture. The larger second-order risk for LMT is that an open, modular drone ecosystem weakens the historic platform-prime moat and shifts a greater share of lifecycle economics toward software-defined subsystems.

LMT's self-funded demonstrator is strategically rational only if it preserves a credible position for follow-on production lots or export variants; otherwise it becomes an R&D charge with no program-of-record recovery. The near-term P&L impact should be immaterial relative to segment cash generation, so the relevant market question over the next 1-3 months is not prototype spending but whether management quantifies investment, targets a production decision, or signals that CCA is displacing capital from buybacks, dividends, or higher-return classified programs. A later Air Force expansion, or software award, would validate the option; a procurement lock-in around initial vendors would impair it over 6-18 months.

Consensus may overstate the direct downside to LMT: losing one vehicle tranche does not determine the much larger integration, weapons, sustainment, and fighter-modernization opportunity. Conversely, investors should not capitalize speculative CCA revenue until unit economics, production quantities, and software ownership are disclosed. The best relative expression is RTX versus LMT/NOC: RTX has a nearer catalyst path from separable awards, while LMT's upside depends on an uncontracted customer reversal.

Key Decisions for Investors

• Initiate a 1-3 month long RTX / short LMT pair at equal defense-beta exposure; target 8-12% relative upside if subsequent software awards reinforce modular procurement. Exit if RTX fails to receive follow-on CCA tasking or LMT discloses a funded production pathway.
• Maintain LMT as core-value exposure but do not add solely on the demonstrator announcement; add only after management provides a bounded R&D spend and confirms no reduction in capital-return cadence. A software award or externally funded flight-test expansion is the confirmation catalyst.
• Keep NOC on watch rather than chase: its software-vendor status has upside, but the missing variables are award scope and contract value. Buy only if a disclosed award establishes meaningful multi-year revenue or if CCA integration is linked to its broader air-dominance franchise.
• Avoid TXT as a direct read-through. The historical comparison highlights the risk of speculative development rather than creating a current earnings catalyst; use any sympathy move as a potential fade absent new funded unmanned-program disclosure.